Insights & Discussion
Moderate chocolate consumption (up to 6 servings per week) is linked to a decreased risk of coronary heart disease, stroke, and diabetes, according to a meta-analysis of prospective studies.
The meta-analysis included 14 prospective studies with a total of 508,705 participants, spanning follow-up durations of 5 to 16 years. The systematic search covered PubMed and Embase through March 2017. Relative risks (RRs) and 95% confidence intervals (CIs) were pooled using random effect models. The study explored the association between chocolate intake and the risk of CHD, stroke, and diabetes, analyzing data on the highest versus lowest chocolate consumption.
The findings indicate that higher chocolate consumption is associated with a reduced risk of CHD, stroke, and diabetes. The relationship follows a nonlinear pattern, with little additional risk reduction observed when consuming chocolate beyond 3 servings per week for CHD and stroke. For diabetes, the peak protective effect emerged at 2 servings per week, with no additional benefit noted beyond 6 servings per week. The study suggests that consuming chocolate in moderation (up to 6 servings per week) may be optimal for preventing these cardiometabolic disorders.
Discover Related Insights
Tart cherry juice shows promise in aiding blood sugar control and supporting heart health, highlighting its potential as a natural dietary addition.
2022 Complementary Therapies in Medicine Effects of tart cherry juice consumption on cardio-metabolic risk factors: A systematic review and meta-analysis of randomized-controlled trials Moosavian SP, Maharat M, Chambari M, Moradi F, Rahimlou M
Systematic Review Blood Sugar Cardiovascular Disease Heart Disease
Tart cherry juice was found to lower fasting blood sugar but didn't have a significant impact on blood pressure, insulin, cholesterol, body fat, or weight. It is rich in antioxidants, which may be why it's beneficial for the heart. Changes in gut bacteria might also play a role. More research with larger and varied groups of people is needed to confirm these findings and understand them better. In the meantime, healthcare professionals may consider suggesting tart cherry juice for heart health.
Consumption of one avocado per day can potentially reduce visceral adiposity and subsequently decrease the risk of diabetes and cardiovascular disease.
2021 Contemporary Clinical Trials The design and rationale of a multi-center randomized clinical trial comparing one avocado per day to usual diet: The Habitual Diet and Avocado Trial (HAT) Reboussin DM, Kris-Etherton PM, Lichtenstein AH, Li Z, Sabate J, Matthan NR, et al.
Randomised Controlled Trial Avocado Cardiometabolic Disease Cardiovascular Disease
The Habitual Diet and Avocado Trial was a multicenter, randomized, controlled study that evaluated the impact of daily avocado consumption over a period of six months. The experiment involved a large and diverse cohort. Participants were required to incorporate a daily avocado into their diet as a substitute for their regular dietary intake, notably those devoid of avocado consumption. Their progress was measured using magnetic resonance imaging (MRI) to ascertain the potential decrease in visceral adiposity, with individuals with increased waist circumference being the primary focus of the study. Additional measures such as hepatic lipid content, plasma lipid profiles, blood pressure and high sensitivity C-reactive protein were also part of the evaluation.
The study showed promising results in terms of weight control and reduction of visceral adiposity among participants. Initial results suggest that the sense of satiety post avocado consumption may subsequently lead to an overall decrease in energy intake. Moreover, the daily consumption of avocados was observed to not only reduce visceral fat but also display potential benefits impacting cardiometabolic disease risk. The benefits of avocado consumption were notably apparent among a cohort with an increased waist circumference, thus confirming the potential health benefits of avocados in weight management and risk reduction of obesity-related diseases.
Regular coffee consumption, due to its bioactive compounds, may have protective effects against chronic disorders and certain neurodegenerative conditions.
2020 International Journal of Molecular Sciences Neuroprotective Effects of Coffee Bioactive Compounds: A Review Socała K, Szopa A, Serefko A, Poleszak E, Wlaź P
Review Article Alzheimer's Disease Cardiovascular Disease Coffee
The paper evaluates the neuroprotective potential of the main bioactive elements in coffee: caffeine, chlorogenic acid, caffeic acid, trigonelline, kahweol, and cafestol. The analysis is focused on the coffee beverage as a complex mixture of these bioactive compounds. The comprehensive study includes in vitro and in vivo preclinical tests to determine the specific health benefits each of these compounds can offer.
The results indicate that regular coffee intake may have defensive effects against a variety of enduring disorders; including cardiovascular disease, type 2 diabetes, obesity, and some forms of cancer. Additionally, an interesting correlation is found between coffee consumption and a lower risk of developing certain neurodegenerative conditions such as Alzheimer's disease, Parkinson's disease, and dementia. The study also highlights that regular coffee intake could possibly lower the risk of stroke. However, the study mentions that the mechanisms enabling these effects are yet to be fully understood.
Consumption of chocolate shows a possible slight reduction in risk for coronary heart disease and stroke, with no association with other chronic diseases studied.
2019 European Journal of Nutrition Chocolate and risk of chronic disease: a systematic review and dose-response meta-analysis Morze J, Schwedhelm C, Bencic A, Hoffmann G, Boeing H, Przybylowicz K, et al.
Systematic Review Dark Chocolate Heart Disease Stroke
Researchers analyzed information available up to July 2018 from PubMed, Embase, and Web of Science, focusing on prospective studies evaluating the correlation between chocolate intake and rates of all-cause mortality, coronary heart disease, stroke, heart failure, type 2 diabetes, colorectal cancer, and hypertension. Meta-analyses using random-effects models were performed, comparing highest and lowest intake categories, and applying linear and non-linear dose-response studies. The NutriGrade scoring system was utilized to assess the credibility of the evidence obtained.
The study's findings were based on 27 identified investigations. It was discovered through linear dose-response meta-analyses that there were no associations of heart failure and type 2 diabetes with each 10 g/day increase in chocolate intake. A small inverse association was found for the risk of coronary heart disease and stroke with each 10 g/day increase in chocolate consumption. The credibility of the evidence was found to be either very low (for all-cause mortality, heart failure, type 2 diabetes, colorectal cancer, or hypertension) or low (for coronary heart disease, stroke).